A Nanocomposite Competent to Overcome Solubility and Permeation Issues of Capsaicin and Thiocolchicoside Simultaneously in Gout Management: Fabrication of Nanocubosomes
March 2024
in “
Saudi Pharmaceutical Journal
”
Studysummary This study found that a nano-cubosome formulation co-loaded with capsaicin and thiocolchicoside enhanced bioavailability and showed promising analgesic and anti-inflammatory effects in rats, potentially benefiting gout management through improved transdermal delivery. Our plain-language summary of this paper — not a Tressless recommendation.
The study developed nanocubosomes (NCs) to improve the solubility and permeation of capsaicin and thiocolchicoside for gout management. Using a Box-Behnken design, the researchers optimized the formulation, achieving a particle size of 206-503 nm and high entrapment efficiency. The NCs demonstrated stability, enhanced drug release, and significant anti-inflammatory and analgesic effects in animal models, with no skin irritation observed. This transdermal delivery system offers a promising alternative to oral therapy, enhancing the bioavailability and efficacy of these drugs in treating gout.
